Welcome To Website IAS

Hot news
Achievement

Independence Award

- First Rank - Second Rank - Third Rank

Labour Award

- First Rank - Second Rank -Third Rank

National Award

 - Study on food stuff for animal(2005)

 - Study on rice breeding for export and domestic consumption(2005)

VIFOTEC Award

- Hybrid Maize by Single Cross V2002 (2003)

- Tomato Grafting to Manage Ralstonia Disease(2005)

- Cassava variety KM140(2010)

Centres
Website links
Vietnamese calendar
Library
Visitors summary
 Curently online :  15
 Total visitors :  7454263

Endometrial carcinoma may favor partial, but not complete, loss of the TGF-β signaling pathway
Thursday, 2019/05/16 | 06:55:27

Ji-Long Liu, Jia-Peng He, Can Zhu, and Hao-Zhuang Cheng

PNAS May 7, 2019 116 (19) 9164-9165

 

The TGF-β signaling pathway is involved in the development of many types of cancer. In two recent PNAS papers, Montsivais et al. (1) and Kriseman et al. (2) of the Matzuk laboratory investigate the role of the TGF-β signaling pathway in endometrial carcinoma by using gene knockout mouse models. They find that either uterine conditional inactivation of TGF-β receptor Alk5 (1) or uterine double-conditional inactivation of Smad2 and Smad3(2), which are transcription factors downstream of the receptor, leads to the development of estrogen-dependent metastatic endometrial cancer. They suggest that the TGF-β signaling pathway may serve as an important tumor suppressor in the uterus. These findings significantly advance our understanding of endometrial carcinoma and open novel avenues for future therapeutic strategies.

 

We are particularly interested in the phenotype difference in these two mouse models: Mice with uterine double-conditional inactivation of Smad2 and Smad3 developed endometrial cancer spontaneously (2), whereas mice with uterine conditional inactivation of Alk5developed endometrial cancer only if they were continuously stimulated by pregnancy (1). According to the University of California, Santa Cruz Genome Browser mouse genome mm9 assembly (3), Alk5Smad2Smad3, and progesterone receptor (Pgr) are located on chr4:47366094–47427796, chr18:76401355–76471401, chr9:63494574–63605801, and chr9:8899833–8968611, respectively. Because Smad3 and Pgr are on the same chromosome, uterine conditional inactivation of Smad3 using Pgr-Cre would only result in haploinsufficiency. Therefore, uterine conditional inactivation of Alk5 may cause complete, whereas uterine double-conditional inactivation of Smad2 and Smad3 may cause only partial, loss of the TGF-β signaling pathway. This may explain the phenotype difference between these two mouse models.

 

There are serval steps during tumorigenesis, from hyperplasia to dysplasia and eventually invasion. In theory, TGF-β can have a dual action in cancer (4): It may inhibit hyperplasia by inducing growth arrest as a tumor suppressor, and it may also enhance tumor cell migration by stimulating epithelial to mesenchymal transition as a tumor promoter. Taking the gene knockout results (12) into consideration, we suspect that endometrial carcinoma may favor partial, but not complete, loss of the TGF-β signaling pathway. Additional evidence in support of this hypothesis was obtained by analyzing human samples of Uterine Corpus Endometrial Carcinoma (UCEC) from The Cancer Genome Atlas (TCGA) project (5). Expression levels of Alk5Smad2, and Smad3 are significantly down-regulated in endometrial cancer tissues compared with the matched noncancer tissues (Fig. 1), indicative of a role as a tumor suppressor. Paradoxically, we found that although Alk5 does not reach the significant threshold, low expression levels of Smad2 and Smad3 are significantly associated with better prognosis and longer survival time in endometrial cancer patients (Fig. 2), which is in line with a role as a tumor promoter (6).

 

In conclusion, by integrating mouse gene knockout results and human endometrial carcinoma gene expression data, we suspect that endometrial carcinoma may favor partial, but not complete, loss of the TGF-β signaling pathway. This pathway may have a dual action as a tumor suppressor and a tumor promoter. This hypothesis deserves further investigation.

 

See https://www.pnas.org/content/116/19/9164

Figure: (AC) Box plots showing the expression of ALK5 (A), SMAD2 (B), and SMAD3 (C) in the cohort of UCEC from TCGA database. RNA sequencing data were used to estimate gene expression levels as fragments per kilobase of transcript per million mapped fragments (FPKM).

Back      Print      View: 1183

[ Other News ]___________________________________________________
  • Egypt Holds Workshop on New Biotech Applications
  • UN Agencies Urge Transformation of Food Systems
  • Taiwan strongly supports management of brown planthopper—a major threat to rice production
  • IRRI Director General enjoins ASEAN states to invest in science for global food security
  • Rabies: Educate, vaccinate and eliminate
  • “As a wife I will help, manage, and love”: The value of qualitative research in understanding land tenure and gender in Ghana
  • CIP Director General Wells Reflects on CIP’s 45th Anniversary
  • Setting the record straight on oil palm and peat in SE Asia
  • Why insect pests love monocultures, and how plant diversity could change that
  • Researchers Modify Yeast to Show How Plants Respond to Auxin
  • GM Maize MIR162 Harvested in Large Scale Field Trial in Vinh Phuc, Vietnam
  • Conference Tackles Legal Obligations and Compensation on Biosafety Regulations in Vietnam
  • Iloilo Stakeholders Informed about New Biosafety Regulations in PH
  • Global wheat and rice harvests poised to set new record
  • GM Maize Harvested in Vietnam Field Trial Sites
  • New label for mountain products puts premium on biological and cultural diversity
  • The Nobel Prize in Physiology or Medicine 2016
  • Shalabh Dixit: The link between rice genes and rice farmers
  • People need affordable food, but prices must provide decent livelihoods for small-scale family farmers
  • GM Seeds Market Growth to Increase through 2020 Due to Rise in Biofuels Use

 

Designed & Powered by WEBSO CO.,LTD